The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
I'm sitting on a 40% loss right now but I don't care. becase the AIHL test is a winner even the BoD are overpaid.
https://www.england.nhs.uk/2022/04/nhs-develops-world-first-bedside-genetic-test-to-prevent-babies-going-deaf/
NHS national medical director Stephen Powis said: “The successful trial of this bedside test is fantastic news for the hundreds of babies – and their parents – who would otherwise lose their hearing when given this common antibiotic in intensive care situations.
Mary said: “Khobi was born with her bowel outside her tummy, which put her at risk of infection – she needed antibiotics quickly but was given this new genetic test which showed she was susceptible to hearing loss from gentamicin.
“She was given an alternative antibiotic which didn’t affect her hearing, and it worked well. She’s doing fine and is such a happy, sociable baby.
“This test is great, and I think all babies should have it”.
Some one doing something correct .
https://lnkd.in/ddVenf_K .
and the test is expected to be routinely used in all the hospitals’ neonatal units within weeks, which are part of Saint Mary’s Managed Clinical Service within the Trust
@roger65
Re your comment yesterday about DB - "Budd won't be selling anything. He's a scientist isn't he?! "
His career path appears to have been in marketing and management, so you would have thought commercialisation and all that involves would be 2nd nature...
https://uk.linkedin.com/in/david-budd-28a25612
Blimey Jay, and you wonder why you didn’t get a response??
Looks like they dangled a carrot in front of us, we’ll get a half year report citing ‘struggles’ in a ‘tough market’ and then a few months of silence whilst people claim
We are selling but it’s being kept a secret for ‘budds mates to get in cheap’
I sent this on the 10th still no reply
Good Morning,
I have a few questions to ask about certain products.
1. The recent UK approval of the POC test, did Genedrive have any leads waiting for this and is there any opportunity’s still out there.
2. What happened to Spain orders with the POC its all gone quite again is this still out going? Last time we had orders with an EU company nothing actually came true.
3. AHIL there’s been a few links on LinkedIn about Spain interested in the product. Are we actively selling in the EU
4.HCV are we due an update on this.
I expect the normal response from yourselves but if you could try answering certain questions this would be great.
Jamie
If you email Anna Dunphy at Walbrook with Budd in cc she responds very quickly - worth a try to see if you get a response.
There are no rns mentioning deals with other companies. ABDX has had at least 3 or 4. Is it because he is hired incompetent sales people????
And, if he truly believed in gdr, he would purchase shares in his own company.
A bad ceo is one who won't invest in his in company in order to inspire confidence.
Wallbrook haven’tresponed to me in months
The more of us that email David Budd with Walbrook in cc directly raising our frustrations the better as his incompetence and lack of updates / sales news is dragging on far too long . The more presssure he is put under the better as far as I am concerned….
What news specifically are you expecting knowing how much you refuse to accept anything it’s probably the NICE report that is due September 2023
PS ..I,m still expecting news this week...!!
Oursales team are selling are products....!!..and as far as Budd not selling anything ....everything will have to be put in front of him to agree the sales contracts.....imho
Budd won't be selling anything. He's a scientist isn't he?! He's hired a sales team to do that and as far as i can see they haven't done much thus far other than try to get distributors on board to...er..do the selling for them and take commission on all future sales revenue. Not really sure what our sales personnel are doing atm
It takes long enough to sell a box of plasters to he NHS never mind a totally new concept of equipment. It swill be on the radar and in use soon but in the good time the NHS timeline and buying managers.
It is little worrying ....the silence.....all I can think of he,s working and selling to all NHS trusts in UK and then he will drop the bomb....and very soon imho ..!!
Have a trawl through AIM and Budd isn't even in the top 100 for bad CEO's. I am sure we all have our own stories Mine involve ODX, RRR and SYME for a start.
This is NOT a DERAMP!!!
In ABDX, the main guys have invested heavily and they are firing out rns after rns of new contracts.
Why is BUDD and his team not doing this? How difficult is it to convince the NHS of the necessity of the
Genedrive® System for Antibiotic Induced Hearing Loss
And get this into hospitals throughout the UK!!
It is a life changing treatment!!
Is it that he is incompetent. Surely at this low price, he could invest in gdr. Such a poor show from a CEO!!!
The Genedrive® COV19-ID kit is a rapid molecular diagnostic test that delivers positive results as quickly as 7.5 minutes and negative results at 17 minutes